Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C1 to C4 side chain modified nodulisporic acid analogs

C1 to C4 side chain modified nodulisporic acid analogs

US Patent 6586452 · Granted Jul 1, 2003

Estimated economic value: $139,410,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PI3K inhibitors and uses thereof2025
Tetragalnac and peptide containing conjugates and methods for delivery of oligon2025
Pyridinone- and pyridazinone-based compounds and uses thereof2024
Bicycle stand2023
Antidiabetic bicyclic compounds2022
Tetragalnac and peptide containing conjugates and methods for delivery of oligon2021
3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetyla2021
Antidiabetic bicyclic compounds2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors2021
Benzo[b]thiophene compounds as STING agonists2020
Benzo[b]thiophene compounds as STING agonists2020
Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors2020